Myomo Reports 2020 Second Quarter Financial Results
Revenue Exceeds Projection as COVID-19 Restrictions Eased Authorization Backlog at Record Level of 120 Units, up 50% Sequentially Conference call begins at 4:30 p.m. Eastern time today CAMBRIDGE, Mass. (August 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from […]
Myomo to Report Second Quarter Financial Results on August 10, 2020
Management to host Financial Results Conference Call at 4:30 p.m. ET CAMBRIDGE, Mass. (August 3, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the […]
Myomo® Launches MyoCare™
New Program Offers Enhanced Support to Maximize the Benefits of MyoPro® to Direct Clients CAMBRIDGE, Mass. (July 9, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the launch of MyoCare™, a new […]
Research Finds MyoPro® Delivers Meaningful Improvements in Motor Function for Brain Injury Patient
Funded by U.S. Department of Defense, Published in Case Report CAMBRIDGE, Mass. (July 6, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that new published research measuring the benefits of the Company’s […]
Myomo Resumes Fitting MyoPro Patients and Deliveries as States Begin to Re-Open after COVID-19 Shutdowns
Q2 Revenue Expected to be in the range of $0.6 million to $0.7 million CAMBRIDGE, Mass. (June 22, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced it has resumed in-person patient visits […]
Myomo® Uses Telehealth Techniques to Conduct Safe Patient Screenings Increased Convenience for Patient Candidates; Increased Productivity and Reduced Costs for Company
CAMBRIDGE, Mass. (June 15, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported the success of its initiative to conduct safe patient screenings remotely using telehealth technologies. Read more.
Myomo Reports 2020 First Quarter Financial Results
21% Year-Over-Year Revenue Growth; 51% Sequential Increase in Authorization Backlog Conference call begins at 4:30 p.m. Eastern time today CAMBRIDGE, Mass. (May 14, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial […]
Myomo to Report First Quarter Financial Results on May 14, 2020
CAMBRIDGE, Mass. (May 12, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2020 on Thursday, May 14, 2020 […]
Myomo Reports Accelerating Growth in MyoPro Pipeline and Record Backlog in the First Quarter of 2020, Provides Update on the Business Impact of COVID-19
CAMBRIDGE, Mass. (April 8, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported its pipeline of MyoPro candidates continued to grow during the first quarter of 2020, with more than 700 candidates awaiting […]
Myomo, Inc., to Present at the New York City based Investor Summit on March 25th-26th
NEW YORK, NY / ACCESSWIRE / March 18, 2020 / Myomo, Inc. (NYSE American:MYO) – A wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will be presenting at this year’s Spring Investor Summit on March 25th-26th. Read more.